New drug trial targets painful skin condition

NCT ID NCT05905783

Terminated Disease control Sponsor: ACELYRIN Inc. Source: ClinicalTrials.gov ↗

Summary

This study tested whether a drug called izokibep could help people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. It involved 258 participants and compared the drug to a placebo. The trial was terminated, meaning it was stopped early.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Clinical Research Site

Birmingham, Alabama, 35233, United States
Clinical Research Site

Scottsdale, Arizona, 85255, United States
Clinical Research Site

Scottsdale, Arizona, 85260, United States
Clinical Research Site

Fayetteville, Arkansas, 72703, United States
Clinical Research Site

Encino, California, 91436, United States
Clinical Research Site

Fountain Valley, California, 92708, United States
Clinical Research Site

Fremont, California, 94538, United States
Clinical Research Site

Los Angeles, California, 90045, United States
Clinical Research Site

Santa Monica, California, 90404, United States
Clinical Research Site

Boca Raton, Florida, 33486, United States
Clinical Research Site

Brandon, Florida, 33511, United States
Clinical Research Site

Coral Gables, Florida, 33134, United States
Clinical Research Site

Hollywood, Florida, 33021, United States
Clinical Research Site

Tampa, Florida, 33607, United States
Clinical Research Site

Tampa, Florida, 33613, United States
Clinical Research Site

Atlanta, Georgia, 30315, United States
Clinical Research Site

Sandy Springs, Georgia, 30328, United States
Clinical Research Site

Savannah, Georgia, 31419, United States
Clinical Research Site

Springfield, Illinois, 62702, United States
Clinical Research Site

Indianapolis, Indiana, 46250, United States
Clinical Research Site

Plainfield, Indiana, 46168, United States
Clinical Research Site

Topeka, Kansas, 66614, United States
Clinical Research Site

Murray, Kentucky, 42071, United States
Clinical Research Site

Baton Rouge, Louisiana, 70808, United States
Clinical Research Site

Baton Rouge, Louisiana, 70809, United States
Clinical Research Site

New Orleans, Louisiana, 70115, United States
Clinical Research Site

Largo, Maryland, 20774, United States
Clinical Research Site

Boston, Massachusetts, 02215, United States
Clinical Research Site

Canton, Michigan, 48187, United States
Clinical Research Site

Troy, Michigan, 48084, United States
Clinical Research Site

Lebanon, New Hampshire, 03766, United States
Clinical Research Site

New York, New York, 10128, United States
Clinical Research Site

Charlotte, North Carolina, 28277, United States
Clinical Research Site

Boardman, Ohio, 44512, United States
Clinical Research Site

Mason, Ohio, 45040, United States
Clinical Research Site

Springfield, Ohio, 45505, United States
Clinical Research Site

Portland, Oregon, 97223, United States
Clinical Research Site

Hershey, Pennsylvania, 17033, United States
Clinical Research Site

Pittsburgh, Pennsylvania, 15213, United States
Clinical Research Site

Sugarloaf, Pennsylvania, 18249, United States
Clinical Research Site

Thompson's Station, Tennessee, 37179, United States
Clinical Research Site

Arlington, Texas, 76011, United States
Clinical Research Site

Frisco, Texas, 75034, United States
Clinical Research Site

Pflugerville, Texas, 78660, United States
Clinical Research Site

San Antonio, Texas, 78218, United States
Clinical Research Site

The Woodlands, Texas, 77380, United States
Clinical Research Site

Webster, Texas, 77598, United States
Clinical Research Site

Springville, Utah, 84663, United States
Clinical Research Site

West Jordan, Utah, 84088, United States
Clinical Research Site

Charlottesville, Virginia, 22908, United States
Clinical Research Site

Edmonton, Alberta, T6G1C3, Canada
Clinical Research Site

Edmonton, Alberta, T6H4J8, Canada
Clinical Research Site

Winnipeg, Manitoba, R3M3Z4, Canada
Clinical Research Site

North Bay, Ontario, P1B 3Z7, Canada
Clinical Research Site

Peterborough, Ontario, K9J5K2, Canada
Clinical Research Site

Toronto, Ontario, M2N3A6, Canada
Clinical Research Site

Toronto, Ontario, M4W2N4, Canada
Clinical Research Site

Toronto, Ontario, M5A3R6, Canada
Clinical Research Site

Waterloo, Ontario, N2J1C4, Canada
Clinical Research Site

Saskatoon, Saskatchewan, S7K2C1, Canada
Clinical Research Site

Dijon, Bourgogne-Franche-Comté, 21000, France
Clinical Research Site

Montpellier, Occitanie, 34090, France
Clinical Research Site

Nantes, Pays de la Loire Region, 44000, France
Clinical Research Site

Toulon, 83000, France
Clinical Research Site

Darmstadt, Hesse, 64283, Germany
Clinical Research Site

Bad Bentheim, Lower Saxony, 48455, Germany
Clinical Research Site

Mainz, Rhineland-Palatinate, 55128, Germany
Clinical Research Site

Leipzig, Saxony, 04103, Germany
Clinical Research Site

Kiel, Schleswig-Holstein, 24148, Germany
Clinical Research Site

Debrecen, Hajdú-Bihar, 4032, Hungary
Clinical Research Site

Zalaegerszeg, Zala County, 8900, Hungary
Clinical Research Site

Budapest, 1036, Hungary
Clinical Research Site

Fukuoka, Fukoka Prefecture, 814-0180, Japan
Clinical Research Site

Kitakyushu, Fukuoka, 807-8555, Japan
Clinical Research Site

Obihiro, Hokkaido Prefecture, 080-0013, Japan
Clinical Research Site

Sapporo, Hokkaido Prefecture, 060-0063, Japan
Clinical Research Site

Kawasaki, Kanagawa, 216-8511, Japan
Clinical Research Site

Yokohama, Kanagawa, 236-0004, Japan
Clinical Research Site

Kyoto, Kyoto, 602-8566, Japan
Clinical Research Site

Osaka, Osaka, 589-8511, Japan
Clinical Research Site

Shinjuku-Ku, Tokyo, 160-0023, Japan
Clinical Research Site

tabashi City, Tokyo, 173-8610, Japan
Clinical Research Site

Nishinomiya, 663-8186, Japan
Clinical Research Site

Krakow, Lesser Poland Voivodeship, 30-001, Poland
Clinical Research Site

Krakow, Lesser Poland Voivodeship, 90-436, Poland
Clinical Research Site

Wroclaw, Lower Silesian Voivodeship, 50-566, Poland
Clinical Research Site

Wroclaw, Lower Silesian Voivodeship, 51-318, Poland
Clinical Research Site

Lublin, Lublin Voivodeship, 20-573, Poland
Clinical Research Site

Katowice, Silesian Voivodeship, 40-611, Poland
Clinical Research Site

Ożarowice, Silesian Voivodeship, 42-624, Poland
Clinical Research Site

Sosnowiec, Silesian Voivodeship, 41-218, Poland
Clinical Research Site

Lodz, Łódź Voivodeship, 90-265, Poland
Clinical Research Site

Seville, Andalusia, 41009, Spain
Clinical Research Site

Palma de Mallorca, Balearic Islands, 07120, Spain
Clinical Research Site

Badalona, Catalonia, 08916, Spain
Clinical Research Site

Barcelona, Catalonia, 08041, Spain
Clinical Research Site

Manises, Valencia, 46940, Spain
Clinical Research Site

Madrid, 28031, Spain

Conditions

Explore the condition pages connected to this study.

HIDRADENITIS SUPPURATIVA